/

In the Heart of Europe

Biomedica is part of the AddLife Group, a publicly traded parent company consisting of various subsidiaries in the Medtech and Labtech fields. AddLife strives to improve people’s lives by being a leading, value-creating player in Life Sciences.

Biomedica is part of the AddLife Group, a publicly traded parent company consisting of various subsidiaries in the Medtech and Labtech fields. AddLife strives to improve people’s lives by being a leading, value-creating player in Life Sciences.

We combine history with future, we speak many languages.

We are bringing out the best of different cultures… combining them.

We have been on the forefront as a distributor of Medical Devices, In Vitro Diagnostics, products for Life Sciences, Biomedica Immunoassays and Clinical IT for more than 40 years.

Our VISION: “We aim high for you – together, for better health”

Our MISSION: “Global Technology – Local Solutions”

We speak scientific and local languages. Inspired by the diversity of regional needs, we combine global technologies to deliver personalized solutions for healthcare, research and industry professionals.

The fundamental principles of our company philosophy with
respect to the following aspects are summarised as follows:

Group Management

Dr. Petra Wiedemann

CEO

Subsidiary Management

Dr. Michaela Weblacher

Sales Director
Sales, Application & Technical Service

Managing Directors

Karin Rappich
Managing Director
Bosnia & Herzegovina
Karin Rappich
Managing Director
Bulgaria
Karin Rappich
Managing Director
Croatia
Ales Donat
Managing Director
Czech Republic
Karoly Toth
Managing Director
Hungary
Vida Peeva-Naumovska
Managing Director
North Macedonia
Norbert Krysiuk
Managing Director
Poland
Karin Rappich
Managing Director
Romania
Karin Rappich
Managing Director
Serbia
Karl Hirczy
Managing Director
Slovakia
Tadej Jesensek
Managing Director
Slovenia
Sheila Huber
Managing Director
Switzerland

History

  • Foundation of Biomedica in Vienna
  • First business br activities in Bulgaria, Poland, Romania and Hungary
  • Development and production of Biomedica Immunoassays (cardiological and osteology marker)
  • Establishment of independent, fully owned subsidiaries in CEE
  • ISO-Certification
  • Decentralization of local management in Poland, Czech Republic, Slovakia and Hungary
  • 12 subsidiaries established to cover the entire CEE region
  • Establishment of independent, fully owned subsidiary in Switzerland
  • AddLife AB acquired Biomedica November 2018